Bristol-Myers Squibb Surges Into Year-End: Why BMY Still Looks Undervalued
Bristol-Myers SquibbBristol-Myers Squibb(US:BMY) Seeking Alpha·2025-12-23 16:17

Core Insights - Bristol-Myers Squibb (BMY) has shown strong performance, finishing 2025 with a market capitalization of $110 billion and an 18% return including dividends since the third quarter [1] Group 1: Company Performance - The stock has returned a solid 18% since the third quarter, indicating positive market sentiment and investor confidence in the company's future prospects [1]

Bristol-Myers Squibb Surges Into Year-End: Why BMY Still Looks Undervalued - Reportify